Agilon Health, Inc.
HealthcareNYSE:AGL · New York Stock Exchange
-$3.25 today
Vol 0.26M · Avg 0.40M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $140.0M |
| Short-term Investments | $91.4M |
| Receivables | $899.7M |
| Other Current | $190.0M |
| Total Current Assets | $1.3B |
| PP&E (Net) | $30.1M |
| Intangible Assets | $62.4M |
| Long-term Investments | $72.1M |
| Other Non-current | $19.0M |
| Total Non-current Assets | $183.8M |
| Total Assets | $1.5B |
Analysis
Selected assets total $1.5B for Latest. The largest visible component is Receivables at $899.7M, about 59.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $173.7M -10.4% | $193.9M +69.6% | $114.3M -75.4% | $465.3M -55.9% | $1.1B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $111.4M -47.4% | $211.7M -44.4% | $380.8M -7.6% | $411.9M | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $673.8M -33.7% | $1.0B +7.9% | $942.5M +91.4% | $492.4M +67.8% | $293.4M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $137.8M +292.1% | $35.1M -17.3% | $42.5M -48.0% | $81.7M +330.8% | $19.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $1.1B -24.8% | $1.5B -1.5% | $1.5B +2.0% | $1.5B +6.1% | $1.4B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $25.4M -31.2% | $37.0M -9.8% | $41.0M +28.3% | $32.0M +52.9% | $20.9M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 -100.0% | $24.1M +0.0% | $24.1M +860.3% | $2.5M | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $65.7M -9.7% | $72.8M +14.1% | $63.8M +245.7% | $18.4M -81.0% | $96.9M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $59.8M -3.2% | $61.8M +38.0% | $44.8M +157.9% | $17.4M +159.4% | $6.7M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $23.7M -70.6% | $80.6M -7.5% | $87.1M -50.5% | $175.9M +86.1% | $94.5M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $174.6M -36.8% | $276.2M +5.9% | $260.8M +5.9% | $246.2M +12.4% | $219.1M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $1.3B -26.7% | $1.7B -0.4% | $1.7B +2.6% | $1.7B +7.0% | $1.6B | $13.3B | $11.9B | $10.6B |
| Account Payables | $1.1B -8.0% | $1.1B +18.7% | $968.1M +102.4% | $478.2M +37.2% | $348.7M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $19.2M +682.0% | $2.5M -73.0% | $9.1M +81.9% | $5.0M -39.8% | $8.3M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $0 | $0 | $0 -100.0% | $51.9M | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $1.1B -6.6% | $1.2B +17.9% | $977.2M +82.6% | $535.1M +49.9% | $357.0M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $15.8M -54.9% | $34.9M +8.0% | $32.3M -16.0% | $38.5M -11.3% | $43.4M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $50.5M -27.4% | $69.5M +16.9% | $59.5M -19.8% | $74.2M -14.1% | $86.4M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $68.1M -38.7% | $111.0M +8.1% | $102.7M -15.7% | $121.8M -11.6% | $137.7M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $1.1B -9.4% | $1.3B +17.0% | $1.1B +64.4% | $656.9M +32.8% | $494.7M | $14.7B | $3.7B | $9.6B |
| Common Stock | $4.1M +0.6% | $4.1M +1.4% | $4.1M -1.5% | $4.1M +3.1% | $4.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$2.0B -24.7% | -$1.6B -19.6% | -$1.3B -24.7% | -$1.1B -11.1% | -$957.7M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $916.0K +1140.9% | -$88.0K +96.2% | -$2.3M +58.7% | -$5.6M | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 +100.0% | -$818.0K -33.9% | -$611.0K -103.7% | -$300.0K | $1.4B | $337.8M | $931.4M |
| Total Equity | $126.7M -73.1% | $471.0M -28.8% | $661.0M -36.5% | $1.0B -4.7% | $1.1B | $9.1B | $7.7B | $3.3B |
| Total Debt | $36.8M -16.3% | $44.0M -16.0% | $52.3M -0.5% | $52.6M -11.8% | $59.6M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$136.9M +8.7% | -$149.9M -141.7% | -$62.0M +85.0% | -$412.7M +58.5% | -$995.2M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Enhabit, Inc.
EHAB
$706.91M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
Charming Medical Limited Class A Ordinary Shares
MCTA
$445.55M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
enGene Holdings Inc.
NASDAQ:ENGN
$82.94M
Nakamoto Inc.
NASDAQ:NAKA
$75.18M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does AGL have?
Agilon Health, Inc. (AGL) reported $173.71M in cash and equivalents in fiscal 2025.
How much debt does AGL carry?
Agilon Health, Inc. (AGL) reported $36.81M of total debt, with net debt of -$136,898,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.